Literature DB >> 19801684

Reactive oxygen species-generating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1alpha gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/histone deacetylase pathway.

Nobuko Koshikawa1, Jun-Ichi Hayashi, Akira Nakagawara, Keizo Takenaga.   

Abstract

Lewis lung carcinoma-derived high metastatic A11 cells constitutively overexpress hypoxia-inducible factor (HIF)-1alpha mRNA compared with low metastatic P29 cells. Because A11 cells exclusively possess a G13997A mutation in the mitochondrial NADH dehydrogenase subunit 6 (ND6) gene, we addressed here a causal relationship between the ND6 mutation and the activation of HIF-1alpha transcription, and we investigated the potential mechanism. Using trans-mitochondrial cybrids between A11 and P29 cells, we found that the ND6 mutation was directly involved in HIF-1alpha mRNA overexpression. Stimulation of HIF-1alpha transcription by the ND6 mutation was mediated by overproduction of reactive oxygen species (ROS) and subsequent activation of phosphatidylinositol 3-kinase (PI3K)-Akt and protein kinase C (PKC) signaling pathways. The up-regulation of HIF-1alpha transcription was abolished by mithramycin A, an Sp1 inhibitor, but luciferase reporter and chromatin immunoprecipitation assays indicated that Sp1 was necessary but not sufficient for HIF-1alpha mRNA overexpression in A11 cells. On the other hand, trichostatin A, a histone deacetylase (HDAC) inhibitor, markedly suppressed HIF-1alpha transcription in A11 cells. In accordance with this, HDAC activity was high in A11 cells but low in P29 cells and in A11 cells treated with the ROS scavenger ebselene, the PI3K inhibitor LY294002, and the PKC inhibitor Ro31-8220. These results suggest that the ROS-generating ND6 mutation increases HIF-1alpha transcription via the PI3K-Akt/PKC/HDAC pathway, leading to HIF-1alpha protein accumulation in hypoxic tumor cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801684      PMCID: PMC2785161          DOI: 10.1074/jbc.M109.054221

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site.

Authors:  Steve Bonello; Christian Zähringer; Rachida S BelAiba; Talija Djordjevic; John Hess; Carine Michiels; Thomas Kietzmann; Agnes Görlach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-01       Impact factor: 8.311

Review 2.  Mitochondrial mutations in cancer.

Authors:  M Brandon; P Baldi; D C Wallace
Journal:  Oncogene       Date:  2006-08-07       Impact factor: 9.867

3.  HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5'UTR.

Authors:  E Minet; I Ernest; G Michel; I Roland; J Remacle; M Raes; C Michiels
Journal:  Biochem Biophys Res Commun       Date:  1999-08-02       Impact factor: 3.575

4.  Hypoxia selects for high-metastatic Lewis lung carcinoma cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors.

Authors:  N Koshikawa; C Maejima; K Miyazaki; A Nakagawara; K Takenaga
Journal:  Oncogene       Date:  2006-02-09       Impact factor: 9.867

5.  Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage.

Authors:  Hiroko P Indo; Mercy Davidson; Hsiu-Chuan Yen; Shigeaki Suenaga; Kazuo Tomita; Takeshi Nishii; Masahiro Higuchi; Yasutoshi Koga; Toshihiko Ozawa; Hideyuki J Majima
Journal:  Mitochondrion       Date:  2006-12-13       Impact factor: 4.160

6.  HDAC inhibitors as anti-inflammatory agents.

Authors:  I M Adcock
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

Review 7.  Redox regulation of the hypoxia-inducible factor.

Authors:  Jacques Pouysségur; Fatima Mechta-Grigoriou
Journal:  Biol Chem       Date:  2006 Oct-Nov       Impact factor: 3.915

8.  Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB.

Authors:  Stilla Frede; Christian Stockmann; Patricia Freitag; Joachim Fandrey
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

9.  HIF-1alpha expression in response to lipopolysaccaride mediates induction of hepatic inflammatory cytokine TNFalpha.

Authors:  Hye Young Kim; Young Hee Kim; Bo-Hye Nam; Hee Jeong Kong; Hyung Hoi Kim; Yoon Jin Kim; Won Gun An; Jaehun Cheong
Journal:  Exp Cell Res       Date:  2007-03-20       Impact factor: 3.905

10.  Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.

Authors:  Hyunjin Noh; Eun Young Oh; Ji Yeon Seo; Mi Ra Yu; Young Ok Kim; Hunjoo Ha; Hi Bahl Lee
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-24
View more
  63 in total

Review 1.  Hypoxic tumor microenvironment: Implications for cancer therapy.

Authors:  Sukanya Roy; Subhashree Kumaravel; Ankith Sharma; Camille L Duran; Kayla J Bayless; Sanjukta Chakraborty
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-27

Review 2.  Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes.

Authors:  Robert B Hamanaka; Navdeep S Chandel
Journal:  Trends Biochem Sci       Date:  2010-04-27       Impact factor: 13.807

3.  Postconditioning attenuates renal ischemia-reperfusion injury by mobilization of stem cells.

Authors:  Xiaohua Tan; Ruili Yin; Yan Chen; Dan Gao; Xiuying Zhang
Journal:  J Nephrol       Date:  2015-02-06       Impact factor: 3.902

Review 4.  Pyruvate kinase M2: A simple molecule with complex functions.

Authors:  Mohammed Alquraishi; Dexter L Puckett; Dina S Alani; Amal S Humidat; Victoria D Frankel; Dallas R Donohoe; Jay Whelan; Ahmed Bettaieb
Journal:  Free Radic Biol Med       Date:  2019-08-08       Impact factor: 7.376

5.  Mitochondrial genome instability in colorectal adenoma and adenocarcinoma.

Authors:  Luiza F de Araujo; Aline S Fonseca; Bruna R Muys; Jessica R Plaça; Rafaela B L Bueno; Julio C C Lorenzi; Anemari R D Santos; Greice A Molfetta; Dalila L Zanette; Jorge E S Souza; Valeria Valente; Wilson A Silva
Journal:  Tumour Biol       Date:  2015-06-12

6.  Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis.

Authors:  Wen Liu; Benjamin H Beck; Kedar S Vaidya; Kevin T Nash; Kyle P Feeley; Scott W Ballinger; Keke M Pounds; Warren L Denning; Anne R Diers; Aimee Landar; Animesh Dhar; Tomoo Iwakuma; Danny R Welch
Journal:  Cancer Res       Date:  2013-12-18       Impact factor: 12.701

7.  Role of sp transcription factors in the regulation of cancer cell metabolism.

Authors:  Michael C Archer
Journal:  Genes Cancer       Date:  2011-07

Review 8.  Updates of reactive oxygen species in melanoma etiology and progression.

Authors:  Feng Liu-Smith; Ryan Dellinger; Frank L Meyskens
Journal:  Arch Biochem Biophys       Date:  2014-04-26       Impact factor: 4.013

9.  A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies.

Authors:  Rana R McKay; Guillermo De Velasco; Lillian Werner; Joaquim Bellmunt; Lauren Harshman; Christopher Sweeney; Jonathan E Rosenberg; Michelle Hirsch; Sabina Signoretti; Eliezer M Van Allen; Meghara Walsh; Ulka Vaishampayan; David F McDermott; Toni K Choueiri
Journal:  Cancer       Date:  2016-05-19       Impact factor: 6.860

Review 10.  Molecular oncology focus - is carcinogenesis a 'mitochondriopathy'?

Authors:  Anna M Czarnecka; Jerzy S Czarnecki; Wojciech Kukwa; Francesco Cappello; Anna Scińska; Andrzej Kukwa
Journal:  J Biomed Sci       Date:  2010-04-25       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.